Literature DB >> 23564405

Metabolic hypertension: concept and practice.

Zhiming Zhu1, Peijian Wang, Shuangtao Ma.   

Abstract

Hypertension is a serious public health problem worldwide. More than 60% of the risk factors for hypertension are associated with metabolic disturbances. Metabolic abnormalities increase the risk for hypertension and cause high blood pressure. Improving metabolic disturbances is beneficial for hypertension treatment. Due to the importance of metabolic abnormalities in the pathogenesis of hypertension, we propose a concept of metabolic hypertension. In this review, we discuss and review the clinical types, pathogenesis, risk evaluation and management of metabolic hypertension. Elucidation of the mechanism of metabolic hypertension should facilitate the design of novel pharmacotherapeutics and dedicated antihypertensive manipulations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23564405     DOI: 10.1007/s11684-013-0264-4

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  47 in total

Review 1.  Hypertension 2010: what was new for the cardiologist?

Authors:  Zbigniew Gaciong; Bartosz Symonides
Journal:  Expert Opin Pharmacother       Date:  2010-11       Impact factor: 3.889

2.  Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension.

Authors:  Dachun Yang; Zhidan Luo; Shuangtao Ma; Wing Tak Wong; Liqun Ma; Jian Zhong; Hongbo He; Zhigang Zhao; Tingbing Cao; Zhencheng Yan; Daoyan Liu; William J Arendshorst; Yu Huang; Martin Tepel; Zhiming Zhu
Journal:  Cell Metab       Date:  2010-08-04       Impact factor: 27.287

Review 3.  Diabetes, hypertension, and cardiovascular disease: an update.

Authors:  J R Sowers; M Epstein; E D Frohlich
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

4.  Increased prevalence of metabolic syndrome among hypertensive population: ten years' trend of the Korean National Health and Nutrition Examination Survey.

Authors:  So-Ryoung Lee; Myung-Jin Cha; Do-Yoon Kang; Kyu-Chul Oh; Dong-Ho Shin; Hae-Young Lee
Journal:  Int J Cardiol       Date:  2011-12-20       Impact factor: 4.164

5.  Effects of telmisartan on fat distribution in individuals with the metabolic syndrome.

Authors:  Michio Shimabukuro; Hideaki Tanaka; Takeshi Shimabukuro
Journal:  J Hypertens       Date:  2007-04       Impact factor: 4.844

Review 6.  Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.

Authors:  Ling Gao; Giovanni E Mann
Journal:  Cardiovasc Res       Date:  2009-01-29       Impact factor: 10.787

7.  Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.

Authors:  Jacqueline M Dekker; Cynthia Girman; Thomas Rhodes; Giel Nijpels; Coen D A Stehouwer; Lex M Bouter; Robert J Heine
Journal:  Circulation       Date:  2005-08-02       Impact factor: 29.690

Review 8.  Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis.

Authors:  Shaista Malik; Nathan D Wong
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-03

9.  Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome.

Authors:  Ozgur Bahadir; Mehmet Uzunlulu; Aytekin Oguz; Muzeyyen A Bahadir
Journal:  Hypertens Res       Date:  2007-01       Impact factor: 3.872

10.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

View more
  3 in total

Review 1.  PPARδ: A Potential Therapeutic Target for the Treatment of Metabolic Hypertension.

Authors:  Yanli Jiang; Qiang Li; Mengxiao Jia; Zhencheng Yan
Journal:  Int J Hypertens       Date:  2019-04-03       Impact factor: 2.420

2.  Cerebral arterial architectonics and CFD simulation in mice with type 1 diabetes mellitus of different duration.

Authors:  Galina Yankova; Darya Tur; Daniil Parshin; Alexander Cherevko; Andrey Akulov
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

3.  Polysaccharide, the Active Component of Dendrobium officinale, Ameliorates Metabolic Hypertension in Rats via Regulating Intestinal Flora-SCFAs-Vascular Axis.

Authors:  Bo Li; Hui-Ying Wang; Jia-Hui Huang; Wan-Feng Xu; Xiao-Jie Feng; Ze-Ping Xiong; Ying-Jie Dong; Lin-Zi Li; Xinglishang He; Han-Song Wu; Ke Zhang; Jie Su; Qiao-Xian Yu; Ning-Hua Jiang; Gui-Yuan Lv; Su-Hong Chen
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.